Hiroshi Ooyama

989 citations
18 papers · 278 indexed · h-index 9

Hiroshi Ooyama

17 papers receiving 275 citations

Peers

Hiroshi Ooyama
Comparison fields: 5 of 46
  • Nephrology 211
  • Pathology and Forensic Medicine 86
  • Rheumatology 48
  • Pharmacology 27
  • Clinical Biochemistry 16
Replace Toshihide Higashino with:
Toshihide Higashino Japan
Lidan Ma China
Barbara Guisan Switzerland
М. С. Елисеев Russia
Marcin Zaniew Poland
Keiko Ooyama Japan
L. D. Fairbanks United Kingdom
Shuzhi Feng China
Shiren Sun China
Mingshu Sun China
Hiroshi Ooyama relative to Toshihide Higashino Japan Toshihide Higashino's profile →
Citations per field
00.5×1.5×2.3×
Toshihide Higashino · 1×
Citations per year

Countries citing papers authored by Hiroshi Ooyama

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Ooyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Ooyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Ooyama more than expected).

Fields of papers citing papers by Hiroshi Ooyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Ooyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Ooyama. The network helps show where Hiroshi Ooyama may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hiroshi Ooyama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hiroshi Ooyama Line = papers co-authored together Hiroshi Ooyama links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1 20244
2 20229
3 202112
4 20214
5 20207
6 20191
7 201853
8 20188
9 20180
10 201713
11 20175
12 201644
13 201618
14 201636
15 201627
16 20162
17 20158
18 201127

About Hiroshi Ooyama

Hiroshi Ooyama is a scholar working on Nephrology, Rheumatology, Pathology and Forensic Medicine, Surgery and Hepatology, having authored 18 papers that have together received 278 indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (16 papers), Alcohol Consumption and Health Effects (7 papers), Case Reports on Hematomas (6 papers), Eosinophilic Disorders and Syndromes (4 papers), Inflammasome and immune disorders (4 papers), Liver Disease Diagnosis and Treatment (2 papers), Dialysis and Renal Disease Management (1 paper) and Liver Disease and Transplantation (1 paper). The work is most often cited by research in Nephrology (211 citations), Pathology and Forensic Medicine (86 citations), Rheumatology (48 citations), Pharmacology (27 citations) and Clinical Biochemistry (16 citations). Hiroshi Ooyama has collaborated with scholars based in Japan, France and United States. Frequent co-authors include Hirotaka Matsuo, Akiyoshi Nakayama, Nariyoshi Shinomiya, Shin Fujimori, Keiko Ooyama, Masayuki Sakiyama, Toshihide Higashino, Kimiyoshi Ichida, Tappei Takada and Hidehiko Moromizato. Their work appears in journals such as Scientific Reports, Human Cell, Modern Rheumatology, Molecular Genetics and Metabolism and Drug Metabolism and Pharmacokinetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026